Delivery Order SPE2DB22D3011-SPE2DB25FP9VW

Award Date 3/13/25
Potential Completion Date 3/14/25
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the procurement of a specific pharmaceutical product, ONFI 10 MG TABLET 100S. The contract has a ceiling value of $4,310.34 and a completion date of January 15, 2025. The contract is a firm-fixed-price delivery order, with no set-aside requirement indicated. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,936.36, is for the delivery of 4566597299 ONFI 10 MG TABLET 100S. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,707.35 firm-fixed-price contract is for the supply of ONFI 10 MG TABLET 100S, a prescription medication. The contract has an ultimate completion date of August 20, 2024. Amerisourcebergen has been awarded numerous indefinite delivery contracts (IDCs) by DLA and other federal agencies, valued up to $999,999,999, to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ONFI 10 MG TABLET 100S. The firm-fixed-price contract, valued at $2,037.53, has an ultimate completion date of August 14, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities to support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565924607 - ONFI 10 MG TABLET 100S. The contract has a firm fixed price of $7,279.54 and a completion date of September 25, 2024. The award is a part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,777.42 Firm Fixed Price Delivery Order contract is for the supply of 4567361471 - ONFI 10 MG TABLET 100S, with a completion date of February 25, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract, valued at $1,928.75, is for the supply of 4565379491 - ONFI 10 MG TABLET 100S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of August 8, 2024. This award is not associated with a set-aside program. Amerisourcebergen has been awarded numerous...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4562437487 ONFI 20 MG TABLET 100S. The $3,294.36 Firm Fixed Price delivery order contract has an ultimate completion date of October 11, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, as well as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of 4,565,564,575 ONFI 10 MG TABLET 100S. The contract has a ceiling value of $4,960.15 and a completion date of August 26, 2024. It is a firm-fixed-price contract with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this delivery order as part of its larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,872.23 firm fixed-price delivery order is for the supply of 4567296220 ONFI 10 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB25FP9VW
    Delivery Order

This is a delivery order contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of 4567571551 ! ONFI 10 MG TABLET 100S. The contract has a firm fixed price of $3,020.68 and a completion date of March 14, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 6/12/25, 10:03 AM